GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Utah Medical Products Inc (NAS:UTMD) » Definitions » ROC (Joel Greenblatt) %

Utah Medical Products (Utah Medical Products) ROC (Joel Greenblatt) %

: 80.60% (As of Dec. 2023)
View and export this data going back to 1999. Start your Free Trial

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Utah Medical Products's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 80.60%.

The historical rank and industry rank for Utah Medical Products's ROC (Joel Greenblatt) % or its related term are showing as below:

UTMD' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 72.53   Med: 111.2   Max: 125.78
Current: 87.17

During the past 13 years, Utah Medical Products's highest ROC (Joel Greenblatt) % was 125.78%. The lowest was 72.53%. And the median was 111.20%.

UTMD's ROC (Joel Greenblatt) % is ranked better than
95.3% of 851 companies
in the Medical Devices & Instruments industry
Industry Median: 0.48 vs UTMD: 87.17

Utah Medical Products's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -3.70% per year.


Utah Medical Products ROC (Joel Greenblatt) % Historical Data

The historical data trend for Utah Medical Products's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Utah Medical Products Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROC (Joel Greenblatt) %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 102.30 72.53 100.59 103.22 87.22

Utah Medical Products Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROC (Joel Greenblatt) % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 107.16 94.70 93.28 80.61 80.60

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Utah Medical Products's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Utah Medical Products ROC (Joel Greenblatt) % Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Utah Medical Products's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Utah Medical Products's ROC (Joel Greenblatt) % falls into.



Utah Medical Products ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3.487 + 9.709 + 0.44199999999999) - (4.177 + 0 + 0)
=9.461

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3.488 + 9.582 + 0.429) - (4.453 + 0 + 0.257)
=8.789

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Utah Medical Products for the quarter that ended in Dec. 2023 can be restated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=15.776/( ( (10.346 + max(9.461, 0)) + (10.551 + max(8.789, 0)) )/ 2 )
=15.776/( ( 19.807 + 19.34 )/ 2 )
=15.776/19.5735
=80.60 %

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Utah Medical Products  (NAS:UTMD) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Utah Medical Products ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Utah Medical Products's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Utah Medical Products (Utah Medical Products) Business Description

Traded in Other Exchanges
Address
7043 South 300 West, Midvale, UT, USA, 84047
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals as well as outpatient clinics and physicians offices.
Executives
Paul O Richins director, officer: VP, Treasurer, Asst. Secretary 7043 SOUTH 300 WEST, MIDVALE UT 84047
Barbara A Payne director
Ernst G Hoyer director
Kevin L Cornwell director, officer: Chairman, CEO, Secretary
Brian Koopman officer: Principal Financial Officer 108 E 1700 S, BOUNTIFUL UT 84010
James H Beeson director 7043 SOUTH 300 WEST, MIDVALE UT 84047
Greg A Leclaire officer: Chief Financial Officer 5225 WILEY POST WAY, SUITE 500, SALT LAKE CITY UT 84116
Stephen W Bennett director